Showing 631-640 of 18561 results for "".
Health Care: Public Policy vs. Insiders Views
https://reachmd.com/programs/clinicians-roundtable/health-care-public-policy-vs-insiders-views/1088/Physicians ask, “What do I need to do right now for this specific patient today to maintain health.” Public Policy advocates ask, “What do we need to do in the future to ensure the health of our society.” How do we reconcile these different viewpoints to become a healthier nation?Updates on Psoriasis Biologics
https://reachmd.com/programs/practical-dermatology/updates-on-psoriasis-biologics/35894/Jashin J. Wu, MD, discusses biologics for psoriasis, including a meta-analyses of best biologics for different types of the condition, at Music City SCALE 2025.Co morbidities Associated with Sleep Apnea--#1
https://reachmd.com/programs/clinicians-roundtable/co-morbidities-associated-with-sleep-apnea-1/565/Dr. Collop discusses various conditions associated with sleep apnea and what type of improvement one might expect if the sleep apnea is treated.Overview of the BRCA Genes
https://reachmd.com/programs/clinicians-roundtable/overview-of-the-brca-genes/421/In this segment, Dr. Critchfield provides an in-depth overview of BRCA genes 1 and 2, including their history of discovery, known functions, and types of mutations.Keys to Closing the Gender Gap in Stroke Trials
https://reachmd.com/programs/neurofrontiers/keys-to-closing-the-gender-gap-in-stroke-trials/13461/Why are women underrepresented in stroke trials, and what can be done to reverse this troubling trend?Interchangeability and Biologics, Biosimilars, and Generics
https://reachmd.com/programs/clinicians-roundtable/interchangeability-and-biologics-biosimilars-and-generics/15987/With the ever-changing landscape of treatments, there are biosimilars for diabetes, inflammatory conditions, and cancers. Read more.Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
https://reachmd.com/programs/eye-on-ocular-health/decoding-variable-responses-to-anti-vegf-therapy-in-amd-and-dme-care/36260/Why do some patients thrive on anti-VEGF therapy while others show limited progress? To find out, Dr. Charles Turck speaks with Dr. Joseph Coney about the underlying factors driving variable responses in age-related macular degeneration (AMD) and diabetic macular edema (DME), including fluid type, lPCOS: The Challenge of Diagnosis and Medical Risk
https://reachmd.com/programs/advances-in-womens-health/pcos-the-challenge-of-diagnosis-and-medical-risk/1878/Polycystic ovary syndrome (PCOS) imperils reproductive age women, posing pressing concerns about fertility, and increasing risk of diabetes, heart disease, and endometrial cancer. Dr. Sam Thatcher, director of the multi-site Center for Applied Reproductive Science, considers the mechanisms of PCOS iAn Overview of Current Management Limitations
https://reachmd.com/programs/cme/An-Overview-of-Current-Management-Limitations/35968/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.New Therapies: The Basics
https://reachmd.com/programs/cme/New-Therapies-The-Basics/35970/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.